Suppr超能文献

西班牙血液学外部质量评估计划(EQAS)的特点与表现。十年经验

Characteristics and performance of the external quality assessment scheme (EQAS) for haematology in Spain. Ten years of experience.

作者信息

Vives-Corrons J L, Gutiérrez G, Jou J M, Reverter J C, Martínez-Brotons F, Domingo A, Iriarte J A

机构信息

Hospital Clínic i Provincial, University of Barcelona, Spain.

出版信息

Ann Ist Super Sanita. 1995;31(1):95-101.

PMID:8546381
Abstract

The external quality assessment scheme for haematology (EQAS-H) in Spain started in 1984 with 56 laboratories, being 473 in 1994. Participants come from public health services (70%) and from private laboratories (30%). Surveys are performed monthly or quarterly depending on the tests and on each occasion the following samples are prepared and sent by the professional organizing team: human (HIV/HBsAg free) or equine whole blood for cell counts (erythrocytes and leucocyte), platelet suspensions for platelet counts, lyophilized plasmas for prothrombin time (PT), partial thromboplastin time (APTT), fibrinogen (F) and antithrombin III (ATIII), and blood films for cell morphology and reticulocyte counts. In 1992 a new scheme on oral anticoagulant treatment control (OATC) has been established jointly by the Spanish Haematology Association (AEHH) and the Spanish Society of Thrombosis and Haemostasis (SETH). After preparation, the control material is sent to participants in the scheme where the requested tests are performed and the results reported back to the organizer (Haematology Laboratory Department of Hospital Clínic i Provincial) for statistical analysis. For evaluating the results, laboratories are divided into four to eight groups depending on the methodologies used. Individual results are assessed against a consensus value (mean) and a deviation index (DI) from the mean, and the coefficient of variation (CV), Youden plots and other statistical information are provided for all results and groups of each parameter. More than 80% of laboratories responded regularly (up to 6 trials) for blood counts and haemoglobin and compared to the previous year (1984), the values of CV(%) improved significantly for RBC count (from 3.3 to 2.2%), haemoglobin (from 2.7 to 2.1%) and platelet count (from 22.6 to 16.3%).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

西班牙血液学外部质量评估计划(EQAS-H)始于1984年,当时有56个实验室参与,1994年达到473个。参与者来自公共卫生服务机构(70%)和私立实验室(30%)。根据检测项目,调查每月或每季度进行一次,每次由专业组织团队制备并发送以下样本:用于细胞计数(红细胞和白细胞)的人(无HIV/HBsAg)或马全血、用于血小板计数的血小板悬液、用于凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、纤维蛋白原(F)和抗凝血酶III(ATIII)的冻干血浆,以及用于细胞形态学和网织红细胞计数的血涂片。1992年,西班牙血液学协会(AEHH)和西班牙血栓与止血协会(SETH)联合制定了一项新的口服抗凝治疗控制(OATC)计划。制备好的对照材料被发送给该计划的参与者,他们进行所需的检测,并将结果反馈给组织者(省立临床医院血液学实验室)进行统计分析。为了评估结果,根据所使用的方法将实验室分为四至八组。将个体结果与共识值(均值)以及与均值的偏差指数(DI)进行比较,并为每个参数的所有结果和组提供变异系数(CV)、尤登图和其他统计信息。超过80%的实验室定期(最多6次试验)回复血细胞计数和血红蛋白检测,与上一年(1984年)相比,红细胞计数的CV(%)值显著改善(从3.3%降至2.2%),血红蛋白(从2.7%降至2.1%),血小板计数(从22.6%降至16.3%)。(摘要截选至250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验